1. Home
  2. TFX vs BCPC Comparison

TFX vs BCPC Comparison

Compare TFX & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFX
  • BCPC
  • Stock Information
  • Founded
  • TFX 1943
  • BCPC 1967
  • Country
  • TFX United States
  • BCPC United States
  • Employees
  • TFX N/A
  • BCPC N/A
  • Industry
  • TFX Medical/Dental Instruments
  • BCPC Major Chemicals
  • Sector
  • TFX Health Care
  • BCPC Industrials
  • Exchange
  • TFX Nasdaq
  • BCPC Nasdaq
  • Market Cap
  • TFX 5.3B
  • BCPC 5.3B
  • IPO Year
  • TFX N/A
  • BCPC N/A
  • Fundamental
  • Price
  • TFX $119.90
  • BCPC $165.02
  • Analyst Decision
  • TFX Hold
  • BCPC Strong Buy
  • Analyst Count
  • TFX 10
  • BCPC 1
  • Target Price
  • TFX $176.50
  • BCPC $180.00
  • AVG Volume (30 Days)
  • TFX 536.7K
  • BCPC 165.9K
  • Earning Date
  • TFX 07-31-2025
  • BCPC 07-25-2025
  • Dividend Yield
  • TFX 1.13%
  • BCPC 0.53%
  • EPS Growth
  • TFX N/A
  • BCPC 17.80
  • EPS
  • TFX 3.20
  • BCPC 4.17
  • Revenue
  • TFX $3,010,144,000.00
  • BCPC $964,544,000.00
  • Revenue This Year
  • TFX $2.98
  • BCPC $8.63
  • Revenue Next Year
  • TFX $4.72
  • BCPC $6.85
  • P/E Ratio
  • TFX $37.45
  • BCPC $39.57
  • Revenue Growth
  • TFX 0.29
  • BCPC 3.76
  • 52 Week Low
  • TFX $115.94
  • BCPC $145.70
  • 52 Week High
  • TFX $249.91
  • BCPC $186.03
  • Technical
  • Relative Strength Index (RSI)
  • TFX 45.92
  • BCPC 57.60
  • Support Level
  • TFX $117.41
  • BCPC $157.19
  • Resistance Level
  • TFX $123.97
  • BCPC $160.79
  • Average True Range (ATR)
  • TFX 2.51
  • BCPC 3.50
  • MACD
  • TFX 0.43
  • BCPC 0.50
  • Stochastic Oscillator
  • TFX 49.32
  • BCPC 97.67

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: